Solute excretion, metabolism, and cardio-renoprotection via two distinct mechanisms revolutionize clinical outcomes.

Friedrich C Luft

Journal: Acta physiologica (Oxford, England) 2021;232(3):e13589

PMID: 33249728

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

Address: Experimental and Clinical Research Center, Charité Medical Faculty, Berlin, Germany.

DOI: 10.1111/apha.13589

Link outs

Free resources

Medical:

https://medlineplus.gov/diabetickidneyproblems.htm...

Subscription / membership required

Full Text Sources:

http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linko...
https://doi.org/10.1111/apha.13589

MeSH Terms: Diabetic Nephropathies, Heart, Humans, Sodium-Glucose Transporter 2 Inhibitors

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.